Type 2 Diabetes

Studies suggest aloe vera has antidiabetic properties, but is the research sound?

In this week's Homerun Slides, the natural history and progression of diabetes.

In this week's Homerun Slides, the principles of the AACE/ACE comprehensive type 2 diabetes management algorithm.

With Sanofi's LixiLan® filed for FDA approval, GLP-1 agonist/basal insulin combinations may be potential game changers.

Is high cholesterol associated with risk of type 2, cardiovascular diseases and high mortality rates?

In part 5, the finale, of this Exclusive Interview, DIC publisher Steve Freed asks about the possibility of expanding the study of the nutritional supplement to address diabetic retinopathy.

In this week's Homerun Slides, part 2 of the Canadian Diabetes Association's specific recommendations for patient-centered diabetes care.

In this week's Homerun Slides, part 4 of the Canadian Diabetes Association's specific recommendations for patient-centered diabetes care.

Novo Nordisk announced positive results on its pipeline GLP-1 candidate, semaglutide, from the phase IIIa trial, SUSTAIN 4 and 5.

In this week's Homerun Slides, the Canadian Diabetes Association lists insulin action and examples of insulin initiation and titration regimens in people with type 2.